\n<\/p>\n
The Switzerland stock market closed on a firm note on Monday, in line with the positive trend seen across Europe, amid optimism about economic recovery despite the continued surge in coronavirus<\/span> cases in several countries.<\/p>\n The benchmark SMI ended stronger by 96.66 points or 0.88% at 11,119.00. The index rose to a high of 11,148.06 around mid morning, and despite paring some gains before noon, recovered well and stayed firm right till the end of the session.<\/p>\n Lonza Group gained about 1.6%. Swiss Re, Partners Group, Roche Holding and Richemont firmed up by 1.3 to 1.4%. Zurich Insurance Group, Swatch Group, ABB, Alcon, LafargeHolcim, Credit Suisse and Geberit gained 0.8 to 1.1%.<\/p>\n Novartis gained about 0.8% after Sandoz, a Novartis unit, said it will begin enrolling the first patient in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study, shortly.<\/p>\n UBS Group, Novartis, Sika, Swiss Life Holding, SGS and Givaudan also closed on a firm note.<\/p>\n Among the stocks in the Swiss Mid Price Index, OC Oerlikon Corp rallied 3.1%, Flughafen Zurich and Straumann Holding both closed higher by about 2%, and Dufry gained 1.6%. <\/p>\n Sonova, Kuehne & Nagel, SIG Combibloc, Swiss Prime Site and AMS also closed notably higher.<\/p>\n Logitech declined by more than 2%, Tecan Group slid 1.6% and Clariant ended lower by about 1.2%, while BB Biotech shed nearly 1%.<\/p>\n On the vaccination front, the Swiss vaccination campaign is reportedly accelerating, despite hiccups and delays with deliveries. <\/p>\n<\/p>\n Market Analysis<\/p>\n<\/div>\n